These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 31982181
1. SMARCB1 (INI1)-deficient thyroid carcinoma: A novel entity expanding the spectrum of tumors with INI1 loss. Agarwal S, Kakkar A, Damle NA, Kumar C, Sarangi J, Subudhi K, Jain D, Sharma MC. Pathol Res Pract; 2020 Apr; 216(4):152830. PubMed ID: 31982181 [Abstract] [Full Text] [Related]
3. SMARCB1-deficient Tumors of Childhood: A Practical Guide. Pawel BR. Pediatr Dev Pathol; 2018 Apr; 21(1):6-28. PubMed ID: 29280680 [Abstract] [Full Text] [Related]
4. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review. Liu Z, Seshadri M, Gupta V, Papanicolau-Sengos A, Merzianu M. Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693 [Abstract] [Full Text] [Related]
7. SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review. Agaimy A, Rau TT, Hartmann A, Stoehr R. Am J Surg Pathol; 2014 Jul; 38(7):910-20. PubMed ID: 24503755 [Abstract] [Full Text] [Related]
13. Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor. Duan Z, Yao K, Yang S, Qu Y, Ren M, Zhang Y, Fan T, Zhao H, Gao J, Feng J, Fan X, Qi X. Mod Pathol; 2022 Dec; 35(12):1910-1920. PubMed ID: 35804041 [Abstract] [Full Text] [Related]
14. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology. Ramalingam P, Croce S, McCluggage WG. Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868 [Abstract] [Full Text] [Related]
15. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Cheng JX, Tretiakova M, Gong C, Mandal S, Krausz T, Taxy JB. Mod Pathol; 2008 Jun; 21(6):647-52. PubMed ID: 18327209 [Abstract] [Full Text] [Related]
17. SMARCB1/INI1-deficient tumors of adulthood. Parker NA, Al-Obaidi A, Deutsch JM. F1000Res; 2020 Jun; 9():662. PubMed ID: 33796273 [Abstract] [Full Text] [Related]
18. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Haberler C, Laggner U, Slavc I, Czech T, Ambros IM, Ambros PF, Budka H, Hainfellner JA. Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089 [Abstract] [Full Text] [Related]
19. The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report. Yoshida K, Fujiwara Y, Goto Y, Kohno T, Yoshida A, Tsuta K, Ohe Y. BMC Cancer; 2018 Apr 07; 18(1):398. PubMed ID: 29625594 [Abstract] [Full Text] [Related]
20. Clinicopathologic study of deciduoid mesothelioma using SMARCB1/INI1 immunohistochemistry and fluorescence in situ hybridization. Kawai T, Ogata S, Nakashima H, Urabe S, Murakami I, Hiroshima K. Hum Pathol; 2019 Nov 07; 93():23-29. PubMed ID: 31445842 [Abstract] [Full Text] [Related] Page: [Next] [New Search]